These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 10929043

  • 1. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
    Nolan B, White B, Smith J, O'Reily C, Fitzpatrick B, Smith OP.
    Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [Abstract] [Full Text] [Related]

  • 3. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 4. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB.
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [Abstract] [Full Text] [Related]

  • 5. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

  • 6. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Apr; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 7. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [Abstract] [Full Text] [Related]

  • 8. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
    White B, Lawler P, Riddell A, Nitu-Whalley IC, Hermans C, Lee CA, Brown SA.
    Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children.
    Akin M, Karapinar DY, Balkan C, Ay Y, Kavakli K.
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):441-8. PubMed ID: 20460340
    [Abstract] [Full Text] [Related]

  • 10. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Oct; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.
    Kavakli K, Hüseyinov A, Coker I, Aydinok Y, Nisli G.
    Haemophilia; 2001 Sep; 7(5):482-9. PubMed ID: 11554936
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Sep; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 17. [Von Willebrand disease: characteristics and response to desmopressin. Study of 103 cases].
    César JM, Avello AG, Vecino A, Cerveró C, Laraña JG, Fuertes IF, Villarrubia J, López J, de Oteyza JP, Velasco JL, Cantalapiedra A, Herrera P, Herrero S, Navarro JL.
    Med Clin (Barc); 1998 Nov 14; 111(16):601-3. PubMed ID: 9881332
    [Abstract] [Full Text] [Related]

  • 18. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep 14; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.